Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus H Frank

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2015
Isolation of Circulating Melanoma CellsJie Ma, Markus H Frank
Anti-Cancer Agents in Medicinal Chemistry|February 27, 2010
Tumor initiation in human malignant melanoma and potential cancer therapiesJie Ma, Markus H Frank
The Journal of Investigative Dermatology|June 16, 2010
The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?Tobias Schatton, Markus H Frank
Pigment Cell & Melanoma Research|March 21, 2008
Cancer stem cells and human malignant melanomaTobias Schatton, Markus H Frank
Annals of the New York Academy of Sciences|October 3, 2009
Antitumor immunity and cancer stem cellsTobias Schatton, Markus H Frank
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2016
Effects of Malignant Melanoma Initiating Cells on T-Cell ActivationTobias Schatton, Ute Schütte, Markus H Frank
The Journal of Clinical Investigation|January 7, 2010
The therapeutic promise of the cancer stem cell conceptNatasha Y Frank, Tobias Schatton, Markus H Frank
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 27, 2009
Identification and targeting of cancer stem cellsTobias Schatton, Natasha Y Frank, Markus H Frank
Clinical and Applied Immunology Reviews|June 29, 2011
P-glycoprotein and alloimmune T-cell activationShona S Pendse, David M Briscoe, Markus H Frank
The Journal of Dermatological Treatment|November 17, 2024
Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical researchElke Niebergall-Roth, Kathrin Dieter, Markus H Frank, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|September 30, 2015
Isolation of Circulating Melanoma CellsJie Ma, Markus H Frank
Anti-Cancer Agents in Medicinal Chemistry|February 27, 2010
Tumor initiation in human malignant melanoma and potential cancer therapiesJie Ma, Markus H Frank
The Journal of Investigative Dermatology|June 16, 2010
The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?Tobias Schatton, Markus H Frank
Pigment Cell & Melanoma Research|March 21, 2008
Cancer stem cells and human malignant melanomaTobias Schatton, Markus H Frank
Annals of the New York Academy of Sciences|October 3, 2009
Antitumor immunity and cancer stem cellsTobias Schatton, Markus H Frank
Methods in Molecular Biology (Clifton, N.J.)|January 21, 2016
Effects of Malignant Melanoma Initiating Cells on T-Cell ActivationTobias Schatton, Ute Schütte, Markus H Frank
The Journal of Clinical Investigation|January 7, 2010
The therapeutic promise of the cancer stem cell conceptNatasha Y Frank, Tobias Schatton, Markus H Frank
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 27, 2009
Identification and targeting of cancer stem cellsTobias Schatton, Natasha Y Frank, Markus H Frank
Clinical and Applied Immunology Reviews|June 29, 2011
P-glycoprotein and alloimmune T-cell activationShona S Pendse, David M Briscoe, Markus H Frank
The Journal of Dermatological Treatment|November 17, 2024
Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical researchElke Niebergall-Roth, Kathrin Dieter, Markus H Frank, et al.
Pageof 8